A human fetal liver-derived infant MLL-AF4 acute lymphoblastic leukemia model reveals a distinct fetal gene expression program

A human fetal liver-derived infant MLL-AF4 acute lymphoblastic leukemia model reveals a distinct fetal gene expression program

Although 90% of children with acute lymphoblastic leukemia (ALL) are now cured, the prognosis for infant-ALL remains dismal. Infant-ALL is usually caused by a single genetic hit that arises in utero: an MLL/KMT2A gene rearrangement (MLL-r). This is sufficient to induce a uniquely aggressive and trea...

Descripció completa

Dades bibliogràfiques
Autors principals:	Rice, S, Jackson, T, Crump, NT, Fordham, N, Elliott, N, O’Byrne, S, Fanego, MDML, Addy, D, Crabb, T, Dryden, C, Inglott, S, Ladon, D, Wright, G, Bartram, J, Ancliff, P, Mead, AJ, Halsey, C, Roberts, I, Milne, TA, Roy, A
Format:	Journal article
Idioma:	English
Publicat:	Springer Nature 2021

Ítems similars

A human fetal liver-derived infant MLL-AF4 acute lymphoblastic leukemia model reveals a distinct fetal gene expression program
per: Siobhan Rice, et al.
Publicat: (2021-11-01)

Developmentally regulated molecular programmes in human fetal haematopoietic cells cooperate with MLL-AF4 to drive infant acute lymphoblastic leukaemia
per: Rice, S
Publicat: (2021)

Human fetal B-lymphopoiesis and acute lymphoblastic leukaemia: the impact of trisomy 21
per: O'Byrne, S
Publicat: (2019)

Discovery of a CD10 negative B-progenitor in human fetal life identifies unique ontogeny-related developmental programs
per: O'Byrne, S, et al.
Publicat: (2019)

PAF1 and FACT cooperate with MLL-AF4 to drive enhancer activity in leukemia
per: Milne, T, et al.
Publicat: (2022)

H3K79me2/3 controls enhancer–promoter interactions and activation of the pan-cancer stem cell marker PROM1/CD133 in MLL-AF4 leukemia cells
per: Godfrey, L, et al.
Publicat: (2020)

The fetal liver lymphoid-primed multipotent progenitor provides the prerequisites for the initiation of t(4;11) MLL-AF4 infant leukemia
per: Camille Malouf, et al.
Publicat: (2018-12-01)

Re-ordering the B cell development hierarchy in human fetal bone marrow: characterisation of a novel human fetal B progenitor
per: O'Byrne, S, et al.
Publicat: (2017)

MLL-AF4 cooperates with PAF1 and FACT to drive high-density enhancer interactions in leukemia
per: Crump, NT, et al.
Publicat: (2023)

Neonatal acute lymphoblastic leukemia (MLL-AF9) with leukemia cutis
per: Yu-Tsung Yin, et al.
Publicat: (2021-11-01)

P332: LIN28B: AN IMPORTANT ONCO-FETAL GENE IN INFANT ACUTE LYMPHOBLASTIC LEUKAEMIA
per: Rebecca Ling, et al.
Publicat: (2023-08-01)

Why are so many MLL lysine methyltransferases required for normal mammalian development?
per: Crump, N, et al.
Publicat: (2019)

The role of MYB in MLL-AF9 leukaemia
per: Lau, IJ
Publicat: (2019)

Aggressive leukemia driven by MLL-AF9
per: Vaia Stavropoulou, et al.
Publicat: (2018-05-01)

The fetal specific gene LIN28B is essential for human fetal b-lymphopoiesis and initiation of KMT2A-AFF1+ infant acute lymphoblastic leukemia
per: Ling, RE, et al.
Publicat: (2024)

Trisomy 21 driven pro-inflammatory signalling in fetal bone marrow may play a role in perturbed B-lymphopoiesis and acute lymphoblastic leukemia of Down syndrome
per: O'Byrne, SI, et al.
Publicat: (2019)

MLL-AF4 cooperates with PAF1 and FACT to drive high-density enhancer interactions in leukemia
per: Nicholas T. Crump, et al.
Publicat: (2023-08-01)

MLL-AF4 Spreading Identifies Binding Sites that Are Distinct from Super-Enhancers and that Govern Sensitivity to DOT1L Inhibition in Leukemia.
per: Kerry, J, et al.
Publicat: (2017)

A fetal tumor suppressor axis abrogates MLL-fusion-driven acute myeloid leukemia
per: Mohamed Eldeeb, et al.
Publicat: (2023-02-01)

Enhanced hemato-endothelial specification during human embryonic differentiation through developmental cooperation between AF4-MLL and MLL-AF4 fusions
per: Clara Bueno, et al.
Publicat: (2019-06-01)

The role of DOT1L in MLL-AF4 leukaemia
per: Godfrey, L
Publicat: (2018)

MLL-AF4 Spreading Identifies Binding Sites that Are Distinct from Super-Enhancers and that Govern Sensitivity to DOT1L Inhibition in Leukemia
per: Jon Kerry, et al.
Publicat: (2017-01-01)

Simultaneous localization of MLL, AF4 and ENL genes in interphase nuclei by 3D-FISH: MLL translocation revisited
per: Sun Jian-Sheng, et al.
Publicat: (2006-01-01)

Next generation sequencing techniques reveal molecular mechanisms of MYB regulation and function in MLL-AF9 Leukemia
per: Lau, I, et al.
Publicat: (2017)

Activity of immunoproteasome inhibitor ONX-0914 in acute lymphoblastic leukemia expressing MLL–AF4 fusion protein
per: Tyler W. Jenkins, et al.
Publicat: (2021-05-01)

The function of PRC2 in MLL-AF4 acute lymphoid leukaemia
per: Tapia, M
Publicat: (2015)

P314: THERAPEUTICALLY TARGETING THE UNIQUE BARCODE OF MLL/AF4
per: R. Cameron, et al.
Publicat: (2022-06-01)

Protocol to establish a stable MLL-AF9_AML mouse model
per: Jun Lu, et al.
Publicat: (2022-09-01)

MLL-AF9 initiates transformation from fast-proliferating myeloid progenitors
per: Xinyue Chen, et al.
Publicat: (2019-12-01)

The MLL family of proteins in normal development and disease
per: Milne, TA
Publicat: (2020)

Molecular and Epigenetic Mechanisms of MLL in Human Leukemogenesis.
per: Ballabio, E, et al.
Publicat: (2012)

P415: A COMPLEX INTERPLAY OF INTRA- AND EXTRACELLULAR FACTORS REGULATES THE OUTCOME OF FETAL- AND ADULT-DERIVED MLL-REARRANGED LEUKEMIA
per: Sudip Ghosh, et al.
Publicat: (2023-08-01)

MLL-AF9 leukemias are sensitive to PARP1 inhibitors combined with cytotoxic drugs
per: Silvia Maifrede, et al.
Publicat: (2017-08-01)

Zoledronic acid inhibits the growth of leukemic MLL-AF9 transformed hematopoietic cells
per: Emanuela Chiarella, et al.
Publicat: (2020-06-01)

MLL rearrangements in pediatric acute lymphoblastic and myeloblastic leukemias: MLL specific and lineage specific signatures
per: te Kronnie Geertruy, et al.
Publicat: (2009-06-01)

Identification of genes transcriptionally responsive to the loss of MLL fusions in MLL-rearranged acute lymphoblastic leukemia.
per: Marieke H van der Linden, et al.
Publicat: (2015-01-01)

Potent, p53-independent induction of NOXA sensitizes MLL-rearranged B-cell acute lymphoblastic leukemia cells to venetoclax
per: Fidyt, K, et al.
Publicat: (2022)

MLL-AF4 binds directly to a BCL-2 specific enhancer and modulates H3K27 acetylation.
per: Godfrey, L, et al.
Publicat: (2016)

Single-cell profiling reveals key differences in the cellular architecture of human haematopoietic stem and progenitor cells throughout fetal and adult life
per: Roy, A, et al.
Publicat: (2018)

A conditional model of MLL-AF4 B-cell tumourigenesis using invertor technology.
per: Metzler, M, et al.
Publicat: (2006)